HK Stock Market Move | INSILICO (03696) rose nearly 6% and announced a strategic cooperation intention with the United Arab Emirates Drug Authority.

INSILICO(03696) rose nearly 6%, as of the time of writing, it rose by 5.81% to HKD 54.65, with a turnover of HKD 40.6374 million. On the news front, on March 5th, according to a message from INSILICO's official WeChat account, the company announced today that it has officially signed a strategic cooperation agreement (MOU) with the Emirates Drug and Equipment (EDE). The two parties will deepen the development of the UAE's pharmaceutical industry through cutting-edge technologies such as AI-enabled drug discovery and development. This cooperation was reached during WHX 2026 (World Health Expo 2026) with the aim of leveraging the strengths of both parties, continuously expanding the scope of cooperation, and building the UAE's independent pharmaceutical R&D capabilities, supporting Innovative Medical Management product evaluation and management, as well as empowering knowledge sharing and professional training to promote collaborative efforts with local research institutions. According to reports, WHX 2026 was held at Dubai Expo City from February 9th to 12th, and INSILICO was invited by the Emirates Drug and Equipment (EDE) to attend. They delivered a keynote speech at the EDE booth, explaining the central role of artificial intelligence and automation technology in accelerating the drug development process through cutting-edge interactive demonstrations. Previously, INSILICO established an AI and quantum computing drug development center in Abu Dhabi. As one of the largest artificial intelligence-driven research hubs in the Middle East, this center is dedicated to advancing drug discovery and the development of the Pharma.AI platform, strengthening cross-innovation in the fields of artificial intelligence and life sciences.